Research examines business database for number of sufferers with prostate most cancers

On this video, Alexander Chehrazi-Raffle, MD, discusses the outcomes of a examine into using transcriptomic signatures to help in number of sufferers with prostate most cancers, offered at ASCO Annual Assembly.

Chehrazi-Raffle, a medical oncologist on the Metropolis of Hope Duarte Most cancers Middle, examined a College of California San Diego examine right into a business database that will likely be integrated into the upcoming PREDICT trial.

“There’s nonetheless way more to come back down the highway, which is an enormous win for sufferers, as these extra customized therapies can supply superior efficacy in comparison with the mutational agnostic choices,” Chehrazi-Raffle stated.

Printed by:

Add matter to electronic mail alerts

Obtain an electronic mail when new articles are posted on

Please present your electronic mail tackle to obtain an electronic mail when new articles are posted on .

“
data-action=”subscribe”>
Subscribe

We have been unable to course of your request. Please attempt once more later. For those who proceed to have this concern please contact customerservice@slackinc.com.

Again to Healio